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Introduction
Branch pulmonary artery stenosis may be primary
due to hypoplasia of the central or peripheral pul-
monary arteries or may develop secondary after
cardiac surgery of congenital heart disease. The re-
sults of surgical treatment are not satisfying, espe-
cially in growing children [23]. Therefore, catheter
interventional treatment has been established as an
alternative option [12, 16]. Two methods of cardiac
interventions are available: balloon angioplasty (BA)
and endovascular stenting have been compared re-
cently [2, 5, 9, 12, 14, 16]. The success rate of both
methods and possible risk factors may influence the
outcome.
The aim of our study was to compare the efficacy
of the two methods in the past 15 years in our insti-
tution with regard to further pulmonary artery growth
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j Abstract Objectives Comparison of the results of branch pulmonary
artery stenosis treated with balloon angioplasty (BA) or stent implanta-
tion (SI) in children. Background Branch pulmonary artery stenosis may
be treated with BA or SI. Methods We compared the results of 147
interventions of branch pulmonary artery stenosis in 87 children (median
age 3.6 years). Patients were treated during 1989–2000 with BA and
during 2001–2004 with SI. Primary endpoints were acute complications
and reintervention during follow up. Secondary variables were age, vessel
diameter increase, acute success rate, balloon/vessel diameter ratio,
pulmonary artery hypoplasia indices, and procedure related factors.
Results The acute vessel diameter increase with BA (4.31 ± 1.98 vs.
7.15 ± 2.31 mm) and SI (3.71 ± 1.58 vs. 6.97 ± 2.68 mm) was significant
within both groups (P < 0.001), but not between both groups. The
reintervention rate was comparable between both groups, but median
time to reintervention was shorter after SI in infants compared to BA.
The balloon/vessel diameter ratio was on average higher in BA than the
stent/vessel diameter ratio in SI (3.49 ± 2.16 vs. 2.42 ± 0.56; P < 0.05)
and was a significant risk factor (P < 0.01) for the higher complication
rate after BA (BA: 14.1% vs. SI: 4.8%). No mortality occurred in both
groups. Conclusion BA and SI are safe interventional catheter therapies
of branch pulmonary artery stenosis. The immediate results of BA and SI
are comparable. The higher complication rate after BA, especially in
infants, was associated with a higher balloon/vessel diameter ratio. SI
seems to be a safe permanent alternative with foreign material, but
requires more reinterventions in infants due to its therapeutic strategy.
j Key words paediatric cardiac interventions – pulmonary angioplasty
– stent – restenosis – right ventricle
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after BA or stent implantation (SI) of branch pul-
monary arteries.
Materials and methods
j Study patients
From November 1989 to October 2004 a total of 87 pa-
tients (46 male and 41 female) underwent 147 inter-
ventional catheter procedures for the treatment of
branch pulmonary artery stenosis. The diagnosis of the
patients are listed in Table 1. A surgical repair for
congenital heart disease was performed in 79 patients
and eight patients had a primary hypoplasia of the
pulmonary arteries. Medical records, hemodynamic
data, angiographies, and lung perfusion scans were re-
viewed. Indications for a catheter interventional pro-
cedure were one or more of the following: (a) elevated
right ventricular systolic pressure (more than 75% of the
left ventricular systolic pressure), (b) relevant stenosis
(stenotic vessel diameter <50% of the surrounding
vessels) of the left or right pulmonary artery leading to
decreased flow of the affected lung (assessed by radi-
onuclid scan or cardiac magnetic resonance imaging),
(c) hypertension of other unobstructed pulmonary ar-
tery segments, or (d) clinical symptoms (exercise
intolerance or increasing cyanosis).
Cardiac interventions were performed for the cen-
tral right (60/147) or left (87/147) pulmonary artery
stenosis. We compared the two techniques (BA vs. SI):
during the years 1989–2000 patients were treated by a
primary BA (n = 92), while during the years 2001–2004
patients (n = 21) were treated by a primary SI. Re-
peated (up to four) cardiac catheterizations with nec-
essary interventional procedures are shown in Fig. 1.
j Technique
Informed parental consent was obtained for all inter-
ventional procedures. The study complies with the
Table 1 Cardiac diagnosis and number of interventions for catheter inter-
ventional treatment of branch pulmonary artery stenosis
Diagnosis Patients
(n = 87)
Interventions
(n = 147)
Postoperative branch pulmonary
artery stenoses
Tetralogy of Fallot 22 35
Pulmonary atresia with VSD 11 24
Double outlet right ventricle
(Fallot type)
3 4
D-transposition of the great arteries
after arterial switch operation
25 50
Truncus arteriosus communis after
repair
7 10
Single ventricle after bidirectional
cavopulmonary anastomosis
7 10
Single ventricle after Fontan
procedure
1 1
Other diagnosisa 3 3
Native branch pulmonary artery stenoses
Isolated peripheral pulmonary artery stenosis
without and 5 6
with Williams Beuren syndrome 3 4
aOther diagnosis are interrupted aortic arch, ventricular septal defect after
pulmonary artery banding, pulmonary atresia without VSD
Cardiac interventions  
n=147 
primary stent 
implantation   
n=21 
redilatation with balloon  
angioplasty   
n=10 
secondary stent  
implantation  
n=15 
redilatation with 
balloon angioplasty  
n=4 
redilatation with balloon  
angioplsty  
n=2 
3. redilatation with 
balloon angioplasty  
n=1
2. redilatation with  
balloon angioplasty  
n=2 
primary   
balloon angioplasty   
n=92 
First 
Second 
Third 
Fourth 
Fig. 1 Eighty-seven patients with branch pulmonary
artery stenosis treated with 147 different catheter
interventional procedures. Fifteen patients after
primary balloon angioplasty were successfully treated
with a secondary stent implantation
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declaration of Helsinki. All procedures were performed
under general anesthesia. Standard hemodynamic
parameters were measured and selective angiographies
were undertaken. The BA technique was performed as
described by others [12]. Balloon inflation time was 10–
60 s depending on the response of the waist and the
degree of interference with cardiac output. Balloons
were inflated for two or three times. The balloon size
was chosen two to six times greater than the diameter of
the treated stenotic vessel segment or 1.5 times greater
than the diameter of the surrounding pre- or postenotic
vessel segments. Different types of BA catheters were
used, high pressure balloons were used in the latter part
of the study. SIs were performed as described by others
[16]. In brief, for the stent intervention procedures the
standard venous sheaths were replaced with a larger
diameter, long sheath over a stiff, exchange wire pre-
viously anchored across the stenosis. The stents were
mounted on low pressure angioplasty balloons with
diameters not exceeding the diameter of the vessel
adjacent to the stenosis. The sheaths were advanced
through the stenosis and the balloon-stent assembly
were advanced within the sheath to the level of the
stenosis. Then the sheath was withdrawn, exposing the
balloon-stent assembly. The correct position of the
balloon-stent assembly was confirmed by repetitive
angiographies. After stent deployment, subsequent
dilatations with low and high pressure balloons opti-
mized the result. The Palmaz Genesis peripheral stents
(Johnson and Johnson, Warren, NJ, USA) and Jostents
(Jomed, Amsterdam, The Netherlands) were used most
frequently. Postdilatation angiographies and hemody-
namic measurements were performed after the inter-
vention (Fig. 2).
The vessel diameter was measured after calibration
with a grid or the catheter diameter. Digitalised an-
giographies were re-evaluated with a vessel diameter
software (Inturis Cardio Image Viewing Package,
Release 1.2, Philips Medical systems, Eindhoven, The
Netherlands). Cross sectional area of the left and right
pulmonary arteries (Nakata index), lower lobe pul-
monary artery index (LL-Nakata), McGoon ratio, and
lower lobe ratio McGoon ratio (LL-McGoon) were
calculated from pulmonary angiograms [1, 15, 18, 19].
For follow up patients underwent clinical evalua-
tion, two-dimensional echocardiography with Dopp-
ler studies or radionuclide scan.
j Criteria for success
The success rate for the interventions were the fol-
lowing: (a) increase of more than 50% of the pre-
dilatation diameter, and (b) decrease of more than
20% of the ratio of right ventricular systolic pressure
to aortic systolic pressure.
j Criteria for complications
As acute complications we included aneurysm for-
mation (defined as a postinterventional increase of
the vessel diameter of more than 150% of the diam-
eter of the surrounding vessels), vessel dissection,
vessel rupture, stent dislocation, stent fracture, or
overstented vessels. Death either related acutely to the
intervention or during follow up were defined as a
major complication.
Fig. 2 Left branch pulmonary artery stenosis in a 2½-year-old child after
operative repair of truncus arteriosus communis (a) treated with implantation
of a Palmaz Genesis stent (b)
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j Criteria for redo
A significant restenosis leading to a repeat catheteri-
zation was defined by a stenotic vessel diameter <50%
of the surrounding vessels measured either if possible
by echocardiography or otherwise by cardiac mag-
netic resonance imaging. Signs of right ventricular
pressure overload an increase of right ventricular
pressure measured by an elevated Doppler flow signal
of the tricuspid regurgitation and signs of hypertro-
phy of the right ventricle in echocardiography served
as additional criteria.
j Criteria for choice of stent or balloon
Primary BA was performed as the method of choice
between the years 1989 and 2000. Although SI was
performed before the year 2000, we ruled out this small
number of patients due to a learning curve. After the
year of 2000 primary stenting was used as the method of
choice for stenosis, which seemed to be untreatable by
BA alone due to elastic recoil after intervention, non-
dilatable fibrotic lesions or external compression.
Secondary stenting was performed in case of unsuc-
cessful primary BA after the year 2000 (Fig. 1).
j Statistical analysis
Data are presented in percentages or relative fre-
quencies for discrete data and as means and standard
deviations or median and range for continuous vari-
ables as appropriate.
Group comparisons were performed by using the
Mann–Whitney U test for continuous variables. Dif-
ferences in proportions were tested by the Chi square
test. Survival analysis (anaylsis of time to reinterven-
tion) was performed with the Kaplan–Meier method
and the Log-rank test for differences between groups.
Logistic regressions were performed with time to a first
complication as primary endpoint and balloon/vessel
diameter ratio, pulmonary artery hypoplasia indices
and age at intervention as risk factors, both in an uni-
variable (one risk factor at a time) and multivariable
analysis (several risk factors combined).
P < 0.05 was considered as significant.
Statistical analysis was performed with SPSS11 for
MacIntosh.
Results
The median age of all 87 patients included for the
study at the time of the first intervention was
3.6 years (range 0.1–19.5 years). Demographic data of
the patients treated with primary BA and with pri-
mary SI are summarized (Table 2).
Determined by the first intervention the patients
were divided into a group treated by primary BA and
into a group treated by primary SI (Fig. 1). The pa-
tients of both groups were comparable concerning
age, body weight, body height, body surface area, X-
ray dose, and procedure time (Table 2). The follow up
period was longer for the patients treated by primary
BA (primary BA: median, 8.5 years; range, 3–15 years
Vs. primary SI: median 1.8 years; range, 0.18–3 years;
P < 0.001).
j First intervention
With a primary BA 92 stenotic pulmonary vessels
were treated (age: median 2.1 years; range 0.1–
19.5 years): The mean diameter of the pulmonary
artery increased from 4.31 ± 1.98 to 7.15 ± 2.31 mm
(P < 0.001) with a relative increase rate of 88.6%.
The mean decrease of the systolic right ventricular/
aortic pressure ratio was from 80.8% to 50.6% (Ta-
ble 3).
With a primary SI 21 pulmonary artery stenosis
were treated (age: median 4.1 years; range 0.1–
17.2 years): The mean diameter of the pulmonary
artery increased from 3.71 ± 1.58 to 6.97 ± 2.68 mm
(P < 0.001) with an increase rate of 102.3%. The mean
decrease in the systolic right ventricular/aortic pres-
sure ratio was from 85.8% to 34.6%.
There was no significant difference between the
mean diameter increase between both groups
(P = 0.86).
The mean balloon/stenosis diameter ratio in pri-
mary BA was higher compared to the mean stent size/
stenosis diameter ratio in primary SI (primary BA:
3.49 ± 2.16 vs. primary SI: 2.42 ± 0.56, P < 0.05)
(Table 2). The success rate (defined as an increase of
more than 50% of vessel diameter) was comparable in
both groups: primary BA 69.6% and primary SI
71.4%.
Table 2 Comparison of different demographic and procedure related param-
eters between the two study groups
Primary balloon
angioplasty
Primary stent
implantation
P value
Age (years) 2.1 (0.01–19.5) 4.1 (0.05–17.2) 0.10
Weight (kg) 11.7 (3.6–84.0) 13.0 (2.8–88.0) 0.19
Height (cm) 85 (52–175) 96 (48–178) 0.15
Surface area (m2) 0.52 (0.23–1.99) 0.59 (0.19–2.10) 0.17
X-ray dose (cGy/m2) 13.3 (4.7–46.9) 13.5 (2.2–62.5) 0.90
Procedure time (min) 98.5 (60–240) 120 (55–180) 0.72
Follow up (years) 8.5 (3–15) 1.8 (0.18–3) <0.001
Median and range are given. Mann–Whitney U test was performed
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The median time to reintervention was shorter
after primary SI compared to the freedom of rein-
tervention after primary BA, but did not reach sta-
tistical significance (P = 0.051) (Fig. 3). But in
patients at an age less than 12 months the freedom of
reintervention was significantly lower (P = 0.04) after
primary SI compared to patients of an age older than
12 months. However, for primary BA no significant
difference in median time to reintervention was ob-
served between children below 12 months and older
children (P = 0.63).
j Second intervention
Thirty-four interventions became necessary due to
our criteria for redo as mentioned above, 29 inter-
ventions in a second cardiac catheterization, four
interventions in a third cardiac catheterization and in
one patient in a fourth cardiac catheterization
(Fig. 1).
The reintervention rate after primary BA was
27.2% during a total follow up of median 8.5 years
(range 0.1–19.5 years). After primary BA redilatation
with BA was performed in 10 cases (median age:
5.4 years; range 1.7–19.1 years) versus secondary
stenting in 15 cases (median age: 9.3 years; range 1.2–
9.3 years).
The reintervention rate after primary SI was 19.1%
during a total follow up of median 1.8 years. After
primary SI redilatation with BA (median age,
1.4 years; range 1.1–3.0 years) became necessary in
four patients. The results of the different reinterven-
tions are summarized in Table 3.
j Complications
The risk for acute complications (aneurysm forma-
tion, vessel dissection, vessel rupture, stent dislo-
cation, stent fracture, or overstented vessels) was
higher after primary BA than after primary SI
(primary BA: 14.1% vs. primary SI: 4.8%) (Table 3).
A multivariable logistic regression analysis with
acute complications as primary endpoint was per-
formed for the following variables balloon (respec-
tively, stent)/vessel diameter ratio, age at
intervention, and pulmonary artery hypoplasia
indices. It revealed balloon (respectively, stent)/
vessel diameter ratio as a significant risk factor for
complications (both in a multivariable regression
with all explanatory variables P = 0.048, and in an
univariable logistic regression P = 0.007).
There was no mortality in both groups.
The rate of minor complications varied in both
groups with the age of the patients (Table 4).
j Pulmonary artery size before the first and second
catheter intervention
The pulmonary artery size before the first and second
catheter intervention was analysed.
The patients treated with primary BA had higher
Nakata indices, McGoon ratios, LL-McGoon, and LL-
Table 3 Results of the different catheter interventions for the treatment of branch pulmonary artery stenosis
First intervention Second intervention
Primary balloon
angioplasty
Primary stent
implantation
Redilatation after
primary balloon
angioplasty
Redilatation after
primary stent
implantation
Secondary stent
implantation
Cardiac interventions 92 21 10 4 15
Median age at intervention 2.1 4.1 5.4 1.4 9.3
Vessel diameter pre-dilatation 4.31 ± 1.98 3.71 ± 1.58 5.63 ± 2.28 2.95 ± 1.18 4.50 ± 1.48
Vessel diameter post-dilatation 7.15 ± 2.31 6.97 ± 2.68 7.54 ± 2.59 4.43 ± 0.71 8.78 ± 2.24
RV/Ao pre-dilatation (%) 80.8 85.8 65.9 - 71.4
RV/Ao post-dilatation (%) 50.6 34.6 60.7 - 66.7
Success rate (%) 69.9 71.4 20.0 50.0 86.7
Complication rate (%) 14.1 4.8 10 0 13.3
Aneurysm formation (n=) 11 0 1 0 1
Vessel dissection (n=) 2 0 0 0 1
Vessel rupture (n=) 0 0 0 0 0
Stent dislocation (n=) – 0 – – 0
Stent fracture (n=) – 0 – – 0
Overstented vessels (n=) – 1 – – 0
Balloon/vessel diameter 3.49 ± 2.16* 2.42 ± 0.56* 2.84 ± 1.43 2.55 ± 0.83 2.85 ± 1.28
RV right ventricle systolic pressure, Ao aortic systolic pressure
* P < 0.05;  P < 0.001. Mann–Whitney U test was performed
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Nakata compared to those treated with primary SI
(Table 5).
j Further possible factors for restenosis leading to
redo
The primary cardiac diagnosis of patients after pri-
mary BA with a restenosis leading to redo (redilata-
tion after primary BA or secondary stent) were mainly
patients with d-transposition of the great arteries
(n = 13) and patients after repair of tetralogy of fallot
(n = 12). In contrast, the primary cardiac diagnosis of
the patients after primary SI suffering from significant
restenosis were patients with pulmonary atresia with
ventricular septal defect with severe hypoplastic pul-
monary arteries (n = 4). An inflation pressure for
primary BA of more than 6 atm resulted in rate of
restenosis leading to redo in 32.3%. A balloon/vessel
diameter ratio of less than 3.0 only resulted in a rate
of restenosis leading to redo in 7.9%.
Discussion
Since more than two decades catheter interventional
treatment of branch pulmonary artery stenosis with
BA and SI is an established treatment [1, 2, 5, 7, 8, 10,
12, 13, 17, 20–22, 25]. The surgical therapy of branch
pulmonary artery stenosis is limited to the central
parts of the pulmonary arteries for technical reasons,
and the results are not satisfying [23]. The aim of the
study was to compare the results of the two methods
for catheter interventional treatment of branch pul-
monary artery stenosis with regard to pulmonary
artery development, success, complications, and re-
intervention.
Both catheter interventional therapies are effective,
safe, and therefore most suitable for children with
different cardiac diagnosis after operative repair of
congenital heart disease or native branch pulmonary
artery stenosis (Table 3). The results after BA in our
population, especially with regard to the initial result
(success rate 70%, complication rate 19%, reinter-
vention rate 27%; follow up 8.5 years), were slightly
better compared to the results described by Rothman
et al. [21] (58%, 6%, 16%, respectively; 10 months),
by Hosking et al. [8] (53%, 5%, 17%, respectively;
37 months) for the 1980s year period and by Zeevi
et al. [27] (56%, 12%, respectively; no further data) for
the early 1990s year period. The higher immediate
success rate may be contributed to a moderately
higher balloon/vessel diameter ratio compared to the
recommendations of other studies [1, 12]. We did not
find any differences between the use of low or high
pressure balloon, even the pressure during dilatation
did not correlate with the outcome [7]. Although we
had no major complications leading to emergency
surgery or death, the higher complication rate in our
patients compared to other studies may partly be
explained in case of dissection or aneurysm formation
by this higher balloon/vessel diameter ratio (Table 3).
In patients younger than 1 year of age we had the
highest rate of complication (Table 4). Nevertheless,
the radiographic assessment in only two planes
without three-dimensional reconstruction concerning
the degree of aneurysm formation, vessel dilatation or
Table 5 Pulmonary artery hypoplasia indices before first and second intervention in both groups
Before first intervention Before second intervention
McGoon
(norm: 1.5–2.0)
Nakata
(norm: 330 ± 30)
LL McG
(norm: 0.7–1.7)
LL Nak
(norm: 120 ± 30)
McGoon
(norm: 1.5–2.0)
Nakata
(norm: 330 ± 30)
LL McG
(norm: 0.7–1.7)
LL Nak
(norm: 120 ± 30)
Primary ballon
angioplasty
n = 74 n = 21
Range 0.91–3.40 45–607 0.67–2.80 17–338 1.42–2.06 26–468 1.43–1.78 22–297
Median 1.90 202 1.62 144 1.88 186 1.58 132
Primary stent
implantation
n = 21 n = 4
Range 1.33–2.09 39–483 1.11–2.09 49–347 0.89–1.78 48–304 0.95–1.44 43–190
Median 1.72 170 1.41 111 0.99 81 0.96 52
P value 0.188 0.039 0.299 0.119 0.05 0.034 0.03 0.115
McGoon McGoon ratio, Nakata Nakata index, LL McG lower lobe McGoon ratio, LL Nak lower lobe Nakata index. Mann–Whitney U test was performed
Table 4 Age distribution of the complication rate in the two groups treated
by primary balloon angioplasty or primary stent implantation
Groups 0–1 year 1–5 years 6–12 years >12 years
Primary balloon angioplasty
Complications/interventions 6/21 5/45 2/20 0/6
Complication rate (%) 28.6 11.1 10.0 0
Primary stent implantation
Complications/interventions 0/6 0/5 1/6 0/4
Complication rate (%) 0 0 16.6 0
The majority of complications occurred in children less than 1 year of age
treated by primary balloon angioplasty
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even vessel dissection might be quite difficult to
compare in very small children. Even an uniform
definition of those morphological entities remains
controversial.
The reintervention rate after BA may be higher due
to the longer follow up compared to the other studies
and may be influenced by the induced vessel trauma
with a higher pressure during dilatation and a high
balloon/vessel diameter ratio. Stenosis mainly oc-
curred postoperatively with scar tissue not showing
the same growth dynamics as native vessels.
The results after SI in our population (success rate
71%, complication rate 5%, reintervention rate 19%;
follow up 1.8 years) were comparable with the results
of other groups: Chau and Leung [2] reported of 12
children undergoing 14 SI with success rate 93%,
complication rate 17%, reintervention rate 17%, and
follow up 26.3 months. McMahon et al. [13] has the
most extensive series, in which he described 338 pa-
tients with 664 pulmonary artery stents implanted
over a follow up of 5.6 years and very low complica-
tion rate 3.8%. Shaffer et al. [22] reported of 200
children undergoing 347 SI within pulmonary vessels
(including 49 children with pulmonary venous ste-
noses stenting) with good immediate results and low
complication rate 8.5%, over a follow up of
14 months.
The therapeutic approach for branch pulmonary
artery stenosis with SI was used in our patients with
more hypoplastic pulmonary arteries (Table 5). To
reduce the complication rate we performed the SI
within the recommended stent/vessel diameter ratios.
Our treatment strategy was cautious for those pa-
tients, if the SI was performed early (<6 months)
during postoperative follow-up. Of course, in paedi-
atric patients this strategy implies the need of further
redilatation during further growth (Fig. 3). We could
demonstrate that redilatation of previously implanted
stents could be performed with a high success rate
and low complication rate (Table 3) [9]. This cir-
cumstance explains the relative high rate of reinter-
vention in patients treated with primary SI, which is
part of the therapeutic approach of a stepwise dila-
tation parallel to the growth of the child. But of course
it has to be considered that those patients with SI will
need a greater number of catheterisation procedures
with a decreasing ease of venous access. Nevertheless,
our success rate was 71% and in those patients, where
we failed an vessel increase of more than 50%, we
were confronted with severly hypoplastic pulmonary
vessels.
The best results of BA have been shown for post-
surgical branch pulmonary artery stenosis, while the
indication for SI for pulmonary artery stenosis is gi-
ven in patients after arterial switch operation [5, 21,
27]. D-transposition of great arteries after arterial
switch operation was the most frequent primary car-
diac diagnosis in patients treated with primary BA
leading to redo with further interventions. SI in
branch pulmonary artery stenosis after LeCompte
maneuver during arterial switch operation seems to
be a more suitable approach due to the morphology of
these stenoses, which is characterized by tension or
traction of the vessel more than scar formation [11].
Tetralogy of Fallot/pulmonary atresia with ventricular
septal defect were the second frequent diagnosis
leading to redo as well after BA as after SI because of
the hypoplastic pulmonary arteries in these types of
congenital heart defects.
These patients could be successfully treated by a
secondary stent implantion after failure of primary
BA (Fig. 1).
Interestingly, all patients with native hypoplastic
pulmonary arteries have been treated with BA with
excellent results [6].
Study limitations were the different length of fol-
low up of the two groups and the circumstance that
not all patients have been recatheterized routinely.
In conclusion, BA and SI are safe interventional
catheter methods for treatment of branch pulmonary
artery stenosis. The immediate results of primary BA
and primary SI are comparable. The higher compli-
cation rate after primary BA, especially in very young
children, may be explained by the used higher bal-
loon/vessel diameter ratio. SI seems to be a safe
alternative, but implies the potential need for further
surgical reoperations in the future.
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Fig. 3 Kaplan–Meier survival analysis comparing the interventional treatment
of branch pulmonary artery stenosis in children with either primary stent
implantation or primary balloon angioplasty. There was no statistical significant
difference between the two methods (P = 0.051). Note, that the reintervention
after primary stent implantation is part of the therapeutic approach which
implies redilatation of the stents during further growth
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Nevertheless, the use of stents in patients with
congenital heart disease is increasing for different
indications [3, 4, 24, 26]. New intravascular stents
continue to be developed and improved. Biodegrad-
able stents seem to be a hopeful alternative for severe
stenosis in very small infants to ‘‘buy time’’ during
further growth [24].
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